PharVision Advisers’s Denny's DENN Stock Holding History

PharVision Advisers’s Portfolio DENN Stock Details DENN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-36,081	Closed	-$218K	–	329
2024 Q4	$218K	Buy	+36,081	New	+$230K	0.18%	265

Other funds holding DENN

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PharVision Advisers's DENN Position: Q1 2025 in Review

PharVision Advisers sold out of Denny's (DENN) in Q1 2025, closing a stake of 36,081 shares — an estimated $218K sold.

PharVision Advisers first reported a position in DENN in Q4 2024 and held it in 1 quarter. The position peaked at $218K in Q4 2024. 141 funds tracked by Wall St. Rank hold DENN as of Q1 2025.

PharVision Advisers reported no remaining Denny's position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 36,081 Denny's shares in Q1 2025, an estimated $218K.
PharVision Advisers first reported a position in Denny's in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Denny's position peaked at $218K in Q4 2024.
141 funds tracked by Wall St. Rank held Denny's as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.